<div id="readability-page-1"><div><p>Certain Common Stock of Guardant Health, Inc. are subject to a Lock-Up Agreement Ending on 5-DEC-2025. These Common Stock will be under lockup for 31 days starting from 4-NOV-2025 to 5-DEC-2025.</p><p>Details:<br/> The company?s directors and executive officers (collectively, the ?Lock-Up Parties?) have agreed, subject to specified exceptions, without the prior written consent of the representative, during the period beginning from the date hereof and continuing to and including the date that is 30 days after the date of the final offering memorandum relating to this offering (the ?Lock-Up Period?), that they will not, without the prior written consent of Goldman Sachs &amp; Co. LLC and Jefferies LLC, (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or exercisable or exchangeable for common stock (including, without limitation, common stock or such other securities which may be deemed to be beneficially owned by such directors, executive officers or stockholders in accordance with the rules and regulations of the SEC and securities which may be issued upon exercise of a stock option or warrant), (ii) engage in any hedging or other transactions designed or intended to lead to or result in, or which could reasonably be expected to lead to or result in, a sale or disposition of any shares of common stock, or securities convertible into or exercisable or exchangeable for shares of common stock, even if any such sale or disposition transaction or transactions would be made or executed by or on behalf of someone other than such directors, executive officers or stockholders, or enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the shares of common stock or such other securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of shares of common stock or such other securities, in cash or otherwise, (iii) make any demand for or exercise any right with respect to the registration of any shares of common stock or any security convertible into or exercisable or exchangeable for shares of common stock, or (iv) publicly disclose the intention to do any of the foregoing. Subject to certain additional limitations.</p></div></div>

<p>Guardant Health, Inc. 的普通股受限售协议的约束，该协议将于 2025 年 12 月 5 日到期。限售期为 31 天，从 2025 年 11 月 4 日至 12 月 5 日。在此期间，董事和高管不得在未获得高盛集团和杰富瑞公司的同意下出售或转让股份，但有特定的例外情况</p>

Guardant Health, Inc.的部分普通股受限于一项锁定协议，该协议将于2025年12月5日到期